230 related articles for article (PubMed ID: 8039496)
1. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1).
Pagès G; Brunet A; L'Allemain G; Pouysségur J
EMBO J; 1994 Jul; 13(13):3003-10. PubMed ID: 8039496
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites.
Gotoh Y; Matsuda S; Takenaka K; Hattori S; Iwamatsu A; Ishikawa M; Kosako H; Nishida E
Oncogene; 1994 Jul; 9(7):1891-8. PubMed ID: 8208535
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of Xenopus mitogen-activated protein (MAP) kinase kinase by MAP kinase kinase kinase and MAP kinase.
Matsuda S; Gotoh Y; Nishida E
J Biol Chem; 1993 Feb; 268(5):3277-81. PubMed ID: 8381423
[TBL] [Abstract][Full Text] [Related]
4. Isolation of ATMEKK1 (a MAP kinase kinase kinase)-interacting proteins and analysis of a MAP kinase cascade in Arabidopsis.
Ichimura K; Mizoguchi T; Irie K; Morris P; Giraudat J; Matsumoto K; Shinozaki K
Biochem Biophys Res Commun; 1998 Dec; 253(2):532-43. PubMed ID: 9878570
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.
Brunet A; Pagès G; Pouysségur J
Oncogene; 1994 Nov; 9(11):3379-87. PubMed ID: 7936666
[TBL] [Abstract][Full Text] [Related]
6. Feedback regulation of mitogen-activated protein kinase kinase kinase activity of c-Raf-1 by insulin and phorbol ester stimulation.
Ueki K; Matsuda S; Tobe K; Gotoh Y; Tamemoto H; Yachi M; Akanuma Y; Yazaki Y; Nishida E; Kadowaki T
J Biol Chem; 1994 Jun; 269(22):15756-61. PubMed ID: 8195229
[TBL] [Abstract][Full Text] [Related]
7. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways.
Takekawa M; Posas F; Saito H
EMBO J; 1997 Aug; 16(16):4973-82. PubMed ID: 9305639
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1).
Brunet A; Pagès G; Pouysségur J
FEBS Lett; 1994 Jun; 346(2-3):299-303. PubMed ID: 8013650
[TBL] [Abstract][Full Text] [Related]
9. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases.
Zheng CF; Guan KL
J Biol Chem; 1993 Nov; 268(32):23933-9. PubMed ID: 8226933
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in madin-darby canine kidney-C7 cells.
Schramek H; Feifel E; Healy E; Pollack V
J Biol Chem; 1997 Apr; 272(17):11426-33. PubMed ID: 9111053
[TBL] [Abstract][Full Text] [Related]
11. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
[TBL] [Abstract][Full Text] [Related]
12. Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk.
Meloche S; Pagès G; Pouysségur J
Mol Biol Cell; 1992 Jan; 3(1):63-71. PubMed ID: 1372523
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways.
Ichijo H; Nishida E; Irie K; ten Dijke P; Saitoh M; Moriguchi T; Takagi M; Matsumoto K; Miyazono K; Gotoh Y
Science; 1997 Jan; 275(5296):90-4. PubMed ID: 8974401
[TBL] [Abstract][Full Text] [Related]
14. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.
Alessandrini A; Greulich H; Huang W; Erikson RL
J Biol Chem; 1996 Dec; 271(49):31612-8. PubMed ID: 8940180
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a novel MAPKKK-independent pathway controlling the stress activated Sty1/Spc1 MAP kinase in fission yeast.
Shieh JC; Martin H; Millar JB
J Cell Sci; 1998 Sep; 111 ( Pt 18)():2799-807. PubMed ID: 9718372
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2.
Butch ER; Guan KL
J Biol Chem; 1996 Feb; 271(8):4230-5. PubMed ID: 8626767
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII.
Seger R; Seger D; Reszka AA; Munar ES; Eldar-Finkelman H; Dobrowolska G; Jensen AM; Campbell JS; Fischer EH; Krebs EG
J Biol Chem; 1994 Oct; 269(41):25699-709. PubMed ID: 7929275
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2.
Wu J; Harrison JK; Dent P; Lynch KR; Weber MJ; Sturgill TW
Mol Cell Biol; 1993 Aug; 13(8):4539-48. PubMed ID: 8393135
[TBL] [Abstract][Full Text] [Related]
19. The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors.
Bianchini L; L'Allemain G; Pouysségur J
J Biol Chem; 1997 Jan; 272(1):271-9. PubMed ID: 8995258
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the MAP kinase pathway.
L'Allemain G
Prog Growth Factor Res; 1994; 5(3):291-334. PubMed ID: 7888635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
